by Aspirion | May 6, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
In this Q&A, Aspirion’s Rikki Ashkin, J.D., Senior Client Success Director, and Thomas Page, J.D., Sr. Director Ops Insights & Enablement, break down what extenuating circumstances are, how they apply across common authorization denial scenarios, and why...
by Aspirion | Apr 22, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Published by Becker’s Healthcare, April 2026 | Author: Aspirion The Denial Crisis Isn’t a Documentation Problem Health systems treating rising denial rates as a documentation issue are misreading the situation. This is the output of a deliberate,...
by Aspirion | Apr 8, 2026 | Artificial Intelligence (AI), Denials Management, Out-of-Network Recovery
Presented to the HFMA South Texas Chapter Clinical denial appeals and No Surprises Act (NSA) disputes aren’t as separate as most teams think. In this session, Aspirion’s revenue cycle experts show how the strategies winning one can strengthen the other....
by Aspirion | Mar 30, 2026 | Artificial Intelligence (AI), Denials Management, Revenue Cycle Management
Published by Becker’s Healthcare, March 2026 | Author: Aspirion The Real Source of Rising Denial Rates Despite investments in Clinical Documentation Improvement programs, clinical denial rates keep climbing—not because of documentation failures, but because...
by Aspirion | Mar 18, 2026 | Artificial Intelligence (AI), Payment Variance Recovery, Revenue Cycle Management, Zero-Balance Review
Hospitals spend enormous energy chasing high-dollar denials. It makes intuitive sense—focus where the money is biggest. But this approach leaves a significant and largely invisible problem unaddressed: the accumulating weight of smaller denied claims that never get...
by Aspirion | Mar 4, 2026 | Artificial Intelligence (AI), Payment Variance Recovery, Revenue Cycle Management, Zero-Balance Review
Hospitals operate on razor-thin margins. For some health systems across the country, net margins hover below 5%—meaning every dollar of revenue carries significant weight. So when industry data suggests that a structured zero-balance review program can recover up...
